| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |